Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...
NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will ...
If you’ve ever taken a crash course in public speaking, you might know about the three rhetorical appeals of ethos, logos, and pathos. While ethos relies on your audience perceiving you as trustworthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results